We recently published a list of 10 Value Stocks in Ken Fisher’s Portfolio. In this article, we are going to take a look at ...

Deciphering where a publicly traded security may move to next is a deceptively difficult exercise. Especially when it comes ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

Zacks Investment Management trimmed its Merck holdings by 18.2%, offloading over 217,000 shares but still clinging to nearly ...

"Unilever will be giving an update on first quarter trading next week, with investors eager to get more insight into the company's evolving strategy under its new CEO, Fernando Fernandez," Hargreaves ...

The stock's rise snapped a three-day losing streak.

Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. The biggest loser of ...

Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ASML Holding is the leading wafer fab equipment leader, and it has a robust EUV systems dominance. Read why I maintain Buy ...

Representative Kelly Morrison recently made several financial moves, highlighted by her sale of Merck & Co. stock valued ...

Shares of Merck & Co. Inc. MRK slid 2.46% to $76.46 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and ...

Merck (NYSE:MRK) entered into a non-exclusive license and option agreement with Cyprumed GmbH, aiming to enhance its peptide offerings through innovative oral delivery technology. Despite this ...